17-44253099-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000342.4(SLC4A1):c.2311+19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00639 in 1,606,888 control chromosomes in the GnomAD database, including 782 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 109 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 673 hom. )
Consequence
SLC4A1
NM_000342.4 intron
NM_000342.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.62
Publications
4 publications found
Genes affected
SLC4A1 (HGNC:11027): (solute carrier family 4 member 1 (Diego blood group)) The protein encoded by this gene is part of the anion exchanger (AE) family and is expressed in the erythrocyte plasma membrane, where it functions as a chloride/bicarbonate exchanger involved in carbon dioxide transport from tissues to lungs. The protein comprises two domains that are structurally and functionally distinct. The N-terminal 40kDa domain is located in the cytoplasm and acts as an attachment site for the red cell skeleton by binding ankyrin. The glycosylated C-terminal membrane-associated domain contains 12-14 membrane spanning segments and carries out the stilbene disulphonate-sensitive exchange transport of anions. The cytoplasmic tail at the extreme C-terminus of the membrane domain binds carbonic anhydrase II. The encoded protein associates with the red cell membrane protein glycophorin A and this association promotes the correct folding and translocation of the exchanger. This protein is predominantly dimeric but forms tetramers in the presence of ankyrin. Many mutations in this gene are known in man, and these mutations can lead to two types of disease: destabilization of red cell membrane leading to hereditary spherocytosis, and defective kidney acid secretion leading to distal renal tubular acidosis. Other mutations that do not give rise to disease result in novel blood group antigens, which form the Diego blood group system. Southeast Asian ovalocytosis (SAO, Melanesian ovalocytosis) results from the heterozygous presence of a deletion in the encoded protein and is common in areas where Plasmodium falciparum malaria is endemic. One null mutation in this gene is known, resulting in very severe anemia and nephrocalcinosis. [provided by RefSeq, Jul 2008]
SLC4A1 Gene-Disease associations (from GenCC):
- autosomal dominant distal renal tubular acidosisInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary spherocytosis type 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal tubular acidosis, distal, 4, with hemolytic anemiaInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- southeast Asian ovalocytosisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- dehydrated hereditary stomatocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary spherocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cryohydrocytosisInheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-44253099-C-T is Benign according to our data. Variant chr17-44253099-C-T is described in ClinVar as Benign. ClinVar VariationId is 255910.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC4A1 | NM_000342.4 | c.2311+19G>A | intron_variant | Intron 17 of 19 | ENST00000262418.12 | NP_000333.1 | ||
| SLC4A1 | XM_011525129.3 | c.2221+19G>A | intron_variant | Intron 16 of 18 | XP_011523431.1 | |||
| SLC4A1 | XM_005257593.6 | c.2116+19G>A | intron_variant | Intron 15 of 17 | XP_005257650.1 | |||
| SLC4A1 | XM_011525130.2 | c.2311+19G>A | intron_variant | Intron 17 of 17 | XP_011523432.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC4A1 | ENST00000262418.12 | c.2311+19G>A | intron_variant | Intron 17 of 19 | 1 | NM_000342.4 | ENSP00000262418.6 | |||
| SLC4A1 | ENST00000399246.3 | c.1213+19G>A | intron_variant | Intron 12 of 14 | 5 | ENSP00000382190.3 |
Frequencies
GnomAD3 genomes AF: 0.00888 AC: 1351AN: 152142Hom.: 110 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1351
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0159 AC: 3876AN: 243402 AF XY: 0.0145 show subpopulations
GnomAD2 exomes
AF:
AC:
3876
AN:
243402
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00613 AC: 8914AN: 1454628Hom.: 673 Cov.: 32 AF XY: 0.00606 AC XY: 4386AN XY: 723832 show subpopulations
GnomAD4 exome
AF:
AC:
8914
AN:
1454628
Hom.:
Cov.:
32
AF XY:
AC XY:
4386
AN XY:
723832
show subpopulations
African (AFR)
AF:
AC:
130
AN:
33476
American (AMR)
AF:
AC:
20
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
6895
AN:
39696
South Asian (SAS)
AF:
AC:
384
AN:
86246
European-Finnish (FIN)
AF:
AC:
10
AN:
46354
Middle Eastern (MID)
AF:
AC:
8
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
801
AN:
1111892
Other (OTH)
AF:
AC:
666
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
471
942
1414
1885
2356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00884 AC: 1346AN: 152260Hom.: 109 Cov.: 32 AF XY: 0.00954 AC XY: 710AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
1346
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
710
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
204
AN:
41552
American (AMR)
AF:
AC:
25
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
987
AN:
5174
South Asian (SAS)
AF:
AC:
47
AN:
4826
European-Finnish (FIN)
AF:
AC:
2
AN:
10612
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62
AN:
68022
Other (OTH)
AF:
AC:
19
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
62
123
185
246
308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
198
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.